Related Articles
Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis
Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer
RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine‑refractory differentiated thyroid carcinoma
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report